Search Results - "Balmforth, A.J."

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Effect of a common X-linked angiotensin II type 2-receptor gene polymorphism (−1332 G/A) on the occurrence of premature myocardial infarction and stenotic atherosclerosis requiring revascularization by Alfakih, K, Brown, B, Lawrance, R.A, Warburton, P, Maqbool, A, Walters, K, Samani, N.J, Ball, S.G, Balmforth, A.J, Hall, A.S

    Published in Atherosclerosis (01-11-2007)
    “…Abstract Objectives To assess the association of the angiotensin II type 2 (AT2 ) receptor (−1332 G/A) gene polymorphism with premature coronary artery disease…”
    Get full text
    Journal Article
  2. 2

    Neprilysin, obesity and the metabolic syndrome by Standeven, K.F, Hess, K, Carter, A.M, Rice, G.I, Cordell, P.A, Balmforth, A.J, Lu, B, Scott, D.J, Turner, A.J, Hooper, N.M, Grant, P.J

    Published in International Journal of Obesity (01-08-2011)
    “…Objective: Neprilysin (NEP), a zinc metalloendopeptidase, has a role in blood pressure control and lipid metabolism. The present study tested the hypothesis…”
    Get full text
    Journal Article
  3. 3

    The influence of SLCO1B1 (OATP1B1) gene polymorphisms on response to statin therapy by Romaine, S P R, Bailey, K M, Hall, A S, Balmforth, A J

    Published in The pharmacogenomics journal (01-02-2010)
    “…Statins (3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors) are well established in the treatment of hypercholesterolaemia and the prevention of…”
    Get full text
    Journal Article
  4. 4

    Functional expression of glucose-dependent insulinotropic polypeptide receptors is coupled to differentiation in a human adipocyte model by Weaver, R.E, Donnelly, D, Wabitsch, M, Grant, P.J, Balmforth, A.J

    Published in International Journal of Obesity (01-11-2008)
    “…Objective: To establish that human adipocytes express functional glucose-dependent insulinotropic peptide (GIP) receptors and in particular the regulation of…”
    Get full text
    Journal Article
  5. 5

    An evaluation of the beta-1 adrenergic receptor Arg389Gly polymorphism in individuals at risk of coronary events. A WOSCOPS substudy by White, H.L., Maqbool, A., McMahon, A.D., Yates, L., Ball, S.G., Hall, A.S., Balmforth, A.J.

    Published in European heart journal (01-07-2002)
    “…Aims The Glycine389 variant of the beta-1 adrenergic receptor generates markedly less cAMP when stimulated in vitro than the more prevalent Arginine389 variant…”
    Get full text
    Journal Article
  6. 6

    The effect of the angiotensin II (AT 1A) receptor stably transfected into human neuroblastoma SH-SY5Y cells on noradrenaline release and changes in intracellular calcium by McDonald, R.L., Balmforth, A.J., Palmer, A.C.V., Ball, S.G., Peers, C., Vaughan, P.F.T.

    Published in Neuroscience letters (20-10-1995)
    “…A stable cell line expressing the angiotensin II (AII) receptor has been obtained by transfecting the human neuroblastoma SH-SY5Y with the plasmid pCEP4…”
    Get full text
    Journal Article
  7. 7

    Isolation and characterization of glyoxylate dehydrogenase from the fungus Sclerotium rolfsii by Balmforth, A.J, Thomson, A

    Published in Biochemical journal (15-02-1984)
    “…Glyoxylate dehydrogenase (glyoxylate:NAD+ oxidoreductase) was purified 600-fold in three steps from crude extracts of the fungus Sclerotium rolfsii (Corticium…”
    Get full text
    Journal Article